Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) closed at $22.67 in the last session, down -0.04% from day before closing price of $22.68. In other words, the price has decreased by -$0.04 from its previous closing price. On the day, 0.52 million shares were traded. BCYC stock price reached its highest trading level at $23.325 during the session, while it also had its lowest trading level at $22.45.
Ratios:
We take a closer look at BCYC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.08 and its Current Ratio is at 8.08. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On July 28, 2022, Barclays started tracking the stock assigning a Overweight rating and target price of $30.Barclays initiated its Overweight rating on July 28, 2022, with a $30 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 11 ’24 when Hannay Michael Charles Ferguso sold 257 shares for $22.49 per share. The transaction valued at 5,780 led to the insider holds 22,891 shares of the business.
Lee Kevin sold 3,158 shares of BCYC for $75,192 on Apr 03 ’24. The CHIEF EXECUTIVE OFFICER now owns 387,270 shares after completing the transaction at $23.81 per share. On Apr 03 ’24, another insider, Crockett Nigel, who serves as the CHIEF BUSINESS OFFICER of the company, sold 955 shares for $23.81 each. As a result, the insider received 22,739 and left with 47,761 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCYC now has a Market Capitalization of 860718720 and an Enterprise Value of 483961824. For the stock, the TTM Price-to-Sale (P/S) ratio is 35.53 while its Price-to-Book (P/B) ratio in mrq is 2.59. Its current Enterprise Value per Revenue stands at 17.94 whereas that against EBITDA is -2.639.
Stock Price History:
Over the past 52 weeks, BCYC has reached a high of $28.91, while it has fallen to a 52-week low of $12.54. The 50-Day Moving Average of the stock is -4.58%, while the 200-Day Moving Average is calculated to be 11.45%.
Shares Statistics:
According to the various share statistics, BCYC traded on average about 397.69K shares per day over the past 3-months and 392760 shares per day over the past 10 days. A total of 42.43M shares are outstanding, with a floating share count of 41.93M. Insiders hold about 1.19% of the company’s shares, while institutions hold 87.19% stake in the company. Shares short for BCYC as of 1711584000 were 2542543 with a Short Ratio of 6.39, compared to 1709164800 on 2764912. Therefore, it implies a Short% of Shares Outstanding of 2542543 and a Short% of Float of 6.79.
